Heat Biologics, Inc. (HTBX): Price and Financial Metrics
HTBX Price/Volume Stats
| Current price | $2.38 | 52-week high | $10.85 |
| Prev. close | $2.37 | 52-week low | $2.07 |
| Day low | $2.33 | Volume | 43,600 |
| Day high | $2.48 | Avg. volume | 171,558 |
| 50-day MA | $2.65 | Dividend yield | N/A |
| 200-day MA | $4.38 | Market Cap | 61.05M |
HTBX Stock Price Chart Interactive Chart >
Heat Biologics, Inc. (HTBX) Company Bio
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.
HTBX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -44.39% |
| 5-year | -25.27% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -43.28% |
| 2020 | 61.20% |
| 2019 | -51.53% |
Continue Researching HTBX
Here are a few links from around the web to help you further your research on Heat Biologics Inc's stock as an investment opportunity:Heat Biologics Inc (HTBX) Stock Price | Nasdaq
Heat Biologics Inc (HTBX) Stock Quote, History and News - Yahoo Finance
Heat Biologics Inc (HTBX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...